New User? Sign Up | Sign In

Insider Trading - Entasis Therapeutics Holdings Inc. (ETTX)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
ETTX Insider Trading Transactions for Entasis Therapeutics Holdings Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-09-28
Purchase
2018-10-02
9:36 pm
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
453,395 $15 $6,800,925 1,623,405
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:38 pm
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
375,887 $15 $5,638,305 1,349,953
(Direct)
View
2018-09-28
Purchase
2018-10-02
9:38 pm
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
453,395 $15 $6,800,925 1,623,405
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:39 pm
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
337,724 $15 $5,065,860 1,180,178
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:40 pm
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
337,724 $15 $5,065,860 1,180,178
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:41 pm
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
337,724 $15 $5,065,860 1,180,178
(Direct)
View
2018-09-28
Purchase
2018-10-02
9:42 pm
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
375,887 $15 $5,638,305 1,349,953
(Indirect)
View
2020-01-09
Sale
2020-01-13
10:47 am
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
Topper James N
FHM LIFE SCIENCES VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
10% Owner
50,000 $5.0002 $250,010 1,299,953
(Direct)
View
2020-06-11
Purchase
2020-06-12
5:34 pm
Entasis Therapeutics Holdings Inc. ETTX Innoviva Inc.
10% Owner
12,677,490 $2.5 $31,693,725 14,000,000
(Direct)
View
2020-09-01
Purchase
2020-09-01
5:31 pm
Entasis Therapeutics Holdings Inc. ETTX Innoviva Inc.
10% Owner
4,672,897 $2.675 $12,499,999 18,672,896
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
361,829 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
323,341 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
412,583 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
7,500,000 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
6,702,213 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
8,552,024 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
337,707 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
251,487 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
320,898 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
7,000,000 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
5,212,833 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
6,651,574 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
361,829 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
323,341 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
412,583 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
7,500,000 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
6,702,213 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
8,552,024 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
359,267 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
458,425 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
7,446,904 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
9,502,249 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
359,267 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
458,425 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
7,446,904 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
9,502,249 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
359,267 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
458,425 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
7,446,904 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
9,502,249 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
337,707 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
251,487 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
320,898 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
7,000,000 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
5,212,833 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
6,651,574 $0 1,349,953
(Indirect)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
11,788 $3.74 24,858
(Direct)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
10,236 $3.11 24,858
(Direct)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
2026-10-21
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
11,788 $3.74 24,858
(Direct)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
2027-11-21
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
10,236 $3.11 24,858
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:56 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Behanna Heather
Director
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:57 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:57 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Gutch Michael
CFO
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:58 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX HASTINGS DAVID C
Director
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:00 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Isaacs Robin
Chief Medical Officer
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:01 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Mueller John Patrick
Chief Development Officer
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:02 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Norden Gregory
Director
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:02 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Perros Manoussos
CEO
123,500 $5.66 123,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:03 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:04 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
15,000 $5.66 15,000
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:02 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:03 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:03 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Behanna Heather
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:03 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Norden Gregory
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:04 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX HASTINGS DAVID C
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:04 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Meek David D.
Director
7,500 $6.12 15,000
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:04 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Meek David D.
Director
15,000 $6.12 15,000
(Direct)
View
2019-08-05
Option Award
2019-08-06
4:10 pm
N/A
2029-08-04
Entasis Therapeutics Holdings Inc. ETTX Mayer Howard
Director
15,000 $6.44 15,000
(Direct)
View
2019-11-04
Option Award
2019-11-06
4:03 pm
N/A
2029-11-03
Entasis Therapeutics Holdings Inc. ETTX Altarac David
Chief Medical Officer
120,000 $5.7 120,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:04 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Mueller John Patrick
Chief Development Officer
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:04 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:05 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Gutch Michael
CFO
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:05 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Keiley Elizabeth M
General Counsel
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:06 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Kimble Eric Wilson
Chief Commercial Officer
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:06 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Perros Manoussos
CEO
145,000 $4.94 145,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:07 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Altarac David
Chief Medical Officer
50,000 $4.94 50,000
(Direct)
View
2020-06-11
Purchase
2020-06-12
5:34 pm
2020-06-11
2025-06-11
Entasis Therapeutics Holdings Inc. ETTX Innoviva Inc.
10% Owner
12,677,490 $2.5 14,000,000
(Direct)
View
2020-09-01
Purchase
2020-09-01
5:31 pm
2020-09-01
2025-09-01
Entasis Therapeutics Holdings Inc. ETTX Innoviva Inc.
10% Owner
4,672,897 $2.675 18,672,896
(Direct)
View
2020-06-10
Option Award
2020-10-06
4:32 pm
N/A
2030-06-09
Entasis Therapeutics Holdings Inc. ETTX Mayer Howard
Director
11,000 $2.98 11,000
(Direct)
View
2020-06-10
Option Award
2020-10-06
4:32 pm
N/A
2030-06-09
Entasis Therapeutics Holdings Inc. ETTX Behanna Heather
Director
11,000 $2.98 11,000
(Direct)
View
2020-06-10
Option Award
2020-10-06
4:32 pm
N/A
2030-06-09
Entasis Therapeutics Holdings Inc. ETTX HASTINGS DAVID C
Director
11,000 $2.98 11,000
(Direct)
View
2020-06-10
Option Award
2020-10-06
4:33 pm
N/A
2030-06-09
Entasis Therapeutics Holdings Inc. ETTX Meek David D.
Director
11,000 $2.98 11,000
(Direct)
View
Goto page 0, 1, Next